OncoGenex Pharma (OGXI) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts OGXI Hot Sheet
Join SI Premium – FREE
OncoGenex Pharma (NASDAQ: OGXI) reported Q3 EPS of ($0.12), $0.14 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
